ScoreWhy is Eli Lilly & Co. ?
1
High Management Efficiency with a high ROCE of 33.55%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 21.74
3
Healthy long term growth as Net Sales has grown by an annual rate of 18.34%
4
With a growth in Net Profit of 105.14%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 10,938.2 MM
- ROCE(HY) Highest at 86.7%
- DIVIDEND PER SHARE(HY) Highest at USD 3.52
5
With ROCE of 38.63%, it has a expensive valuation with a 14.99 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 26.80%, its profits have risen by 54.2% ; the PEG ratio of the company is 0.9
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Eli Lilly & Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Eli Lilly & Co. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Eli Lilly & Co.
47.95%
0.41
40.64%
S&P 500
22.99%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
21.58%
EBIT Growth (5y)
34.09%
EBIT to Interest (avg)
21.74
Debt to EBITDA (avg)
1.64
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.93
Tax Ratio
18.34%
Dividend Payout Ratio
26.14%
Pledged Shares
0
Institutional Holding
84.61%
ROCE (avg)
33.55%
ROE (avg)
83.66%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
31.29
EV to EBIT
29.15
EV to EBITDA
27.31
EV to Capital Employed
13.96
EV to Sales
13.28
PEG Ratio
0.54
Dividend Yield
NA
ROCE (Latest)
47.90%
ROE (Latest)
86.28%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend37What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 20,480.4 MM
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
ROCE(HY)
Highest at 107.64%
DIVIDEND PER SHARE(HY)
Highest at USD 4.11
NET SALES(Q)
Highest at USD 19,799 MM
OPERATING PROFIT(Q)
Highest at USD 10,287 MM
PRE-TAX PROFIT(Q)
Highest at USD 9,616 MM
NET PROFIT(Q)
Highest at USD 8,036.15 MM
RAW MATERIAL COST(Y)
Fallen by 0.74% (YoY
CASH AND EQV(HY)
Highest at USD 12,550 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 122.08 %
DEBTORS TURNOVER RATIO(HY)
Highest at 4.11 times
OPERATING PROFIT MARGIN(Q)
Highest at 51.96 %
EPS(Q)
Highest at USD 8.26
-1What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)
Lowest at 20.96%
Here's what is working for Eli Lilly & Co.
Operating Cash Flow
Highest at USD 20,480.4 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 19,799 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD 10,287 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 9,616 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 8,036.15 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Dividend per share
Highest at USD 4.11 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Sales
At USD 19,799 MM has Grown at 21.51%
over average net sales of the previous four periods of USD 16,294.75 MMMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at 51.96 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
At USD 8,036.15 MM has Grown at 40.41%
over average net sales of the previous four periods of USD 5,723.29 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 8.26
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 12,550 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 122.08 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 4.11 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 0.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Eli Lilly & Co.
Dividend Payout Ratio
Lowest at 20.96%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
